Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/19/14 → 3/19/20 |
Funding
- SCRI Development Innovations, LLC (Prot #CX-839-003 // Prot #CX-839-003)
- Calithera Biosciences, Inc. (Prot #CX-839-003 // Prot #CX-839-003)
Prot #CX-839-003: A Phase 1 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Glutaminase Inhibitor CB-839 in Patients with Relapsed and/or Treatment-Refractory Leukemia
- Frankfurt, Olga (PD/PI)
Project: Research project